Clinical Trial: A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD

U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07717892) titled 'A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD' on July 16.

Brief Summary: This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to <18 years with ADHD.

Study Start Date: June 25

Study Type: INTERVENTIONAL

Condition: ADHD

Intervention: DRUG: Solriamfetol Dose A

Solriamfetol capsules, taken once daily

DRUG: Solriamfetol Dose B

Solriamfetol capsules, taken once daily

DRUG: Placebo

Placebo capsules, taken once daily

Recruitment Status: RECRUITING

Sponsor: A...